These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19726031)

  • 1. Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia.
    Piontkewitz Y; Assaf Y; Weiner I
    Biol Psychiatry; 2009 Dec; 66(11):1038-46. PubMed ID: 19726031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracing the development of psychosis and its prevention: what can be learned from animal models.
    Piontkewitz Y; Arad M; Weiner I
    Neuropharmacology; 2012 Mar; 62(3):1273-89. PubMed ID: 21703648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia.
    Piontkewitz Y; Arad M; Weiner I
    Schizophr Bull; 2011 Nov; 37(6):1257-69. PubMed ID: 20439320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal trajectories of neurodevelopment and behavior following in utero insult in the rat.
    Piontkewitz Y; Arad M; Weiner I
    Biol Psychiatry; 2011 Nov; 70(9):842-51. PubMed ID: 21816387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia.
    Meyer U; Spoerri E; Yee BK; Schwarz MJ; Feldon J
    Schizophr Bull; 2010 May; 36(3):607-23. PubMed ID: 18845557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia.
    Zuckerman L; Rehavi M; Nachman R; Weiner I
    Neuropsychopharmacology; 2003 Oct; 28(10):1778-89. PubMed ID: 12865897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring.
    Zuckerman L; Weiner I
    J Psychiatr Res; 2005 May; 39(3):311-23. PubMed ID: 15725430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia.
    Ozawa K; Hashimoto K; Kishimoto T; Shimizu E; Ishikura H; Iyo M
    Biol Psychiatry; 2006 Mar; 59(6):546-54. PubMed ID: 16256957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A putative animal model of the "prodromal" state of schizophrenia.
    Tenn CC; Fletcher PJ; Kapur S
    Biol Psychiatry; 2005 Mar; 57(6):586-93. PubMed ID: 15780845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of clozapine on memory function in the rat neonatal hippocampal lesion model of schizophrenia.
    Levin ED; Christopher NC
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):223-9. PubMed ID: 16356617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia.
    Meyer U; Feldon J; Schedlowski M; Yee BK
    Neurosci Biobehav Rev; 2005; 29(6):913-47. PubMed ID: 15964075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
    Gaisler-Salomon I; Weiner I
    Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood.
    Ibi D; Nagai T; Kitahara Y; Mizoguchi H; Koike H; Shiraki A; Takuma K; Kamei H; Noda Y; Nitta A; Nabeshima T; Yoneda Y; Yamada K
    Neurosci Res; 2009 Jul; 64(3):297-305. PubMed ID: 19447299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine.
    Weiner I; Shadach E; Tarrasch R; Kidron R; Feldon J
    Biol Psychiatry; 1996 Nov; 40(9):834-43. PubMed ID: 8896769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal immune activation by polyriboinosinic-polyribocytidilic acid injection produces synaptic dysfunction but not neuronal loss in the hippocampus of juvenile rat offspring.
    Oh-Nishi A; Obayashi S; Sugihara I; Minamimoto T; Suhara T
    Brain Res; 2010 Dec; 1363():170-9. PubMed ID: 20863817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: amelioration by COX-2 inhibition.
    Zavitsanou K; Lim CK; Purves-Tyson T; Karl T; Kassiou M; Banister SD; Guillemin GJ; Weickert CS
    Brain Behav Immun; 2014 Oct; 41():173-81. PubMed ID: 24878170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats.
    Piontkewitz Y; Bernstein HG; Dobrowolny H; Bogerts B; Weiner I; Keilhoff G
    Brain Behav Immun; 2012 Feb; 26(2):353-63. PubMed ID: 22154704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic nicotine interactions with clozapine and risperidone and attentional function in rats.
    Rezvani AH; Caldwell DP; Levin ED
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):190-7. PubMed ID: 16310917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia.
    Lieberman JA
    J Clin Psychiatry; 1999; 60 Suppl 12():9-12. PubMed ID: 10372603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of JL13, a pyridobenzoxazepine with potential atypical antipsychotic activity, in animal models for schizophrenia.
    Ellenbroek BA; Liégeois JF; Bruhwyler J; Cools AR
    J Pharmacol Exp Ther; 2001 Jul; 298(1):386-91. PubMed ID: 11408566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.